Compositions of cyclin dependent kinase 7 (CDK7) inhibitor
US11083728B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 3, 2018 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Apr 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, in part, compositions comprising an inhibitor of cyclin-dependent kinase 7 (CDK7) and sulfobutyl ether-β-cyclodextrin. Also provided are methods of using a disclosed composition for treating proliferative diseases. The present invention also provides methods of making disclosed compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.